Invesco Exchange-Traded Fund Trust II. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Private Prime FundCash or money market | 14.20% | $9.57M | 9,567,964 |
| Gilead Sciences, Inc.GILD | 7.39% | $4.98M | 37,039 |
| Vertex Pharmaceuticals Inc.VRTX | 7.38% | $4.97M | 11,104 |
| Amgen Inc.AMGN | 7.10% | $4.79M | 14,213 |
| Invesco Private Government FundCash or money market | 5.48% | $3.69M | 3,691,132 |
| Regeneron Pharmaceuticals, Inc.REGN | 5.08% | $3.42M | 5,570 |
| Alnylam Pharmaceuticals, Inc.ALNY | 3.19% | $2.15M | 7,110 |
| Revolution Medicines, Inc.RVMD | 2.48% | $1.67M | 10,624 |
| Biogen Inc.BIIB | 2.29% | $1.54M | 7,868 |
| Illumina, Inc.ILMN | 1.98% | $1.34M | 8,197 |
| United Therapeutics Corp.UTHR | 1.94% | $1.31M | 2,350 |
| Royalty Pharma PLCRPRX | 1.90% | $1.28M | 22,968 |
| argenx SEARGX | 1.89% | $1.27M | 1,521 |
| Insmed Inc.INSM | 1.83% | $1.24M | 11,556 |
| Roivant Sciences Ltd.ROIV | 1.71% | $1.15M | 38,370 |
| Incyte Corp.INCY | 1.53% | $1.03M | 10,669 |
| Viatris Inc.VTRS | 1.49% | $1.00M | 61,728 |
| Moderna, Inc.MRNA | 1.48% | $999.15K | 21,173 |
| Guardant Health, Inc.GH | 1.35% | $911.98K | 7,032 |
| Neurocrine Biosciences, Inc.NBIX | 1.26% | $851.81K | 5,381 |
| Jazz Pharmaceuticals PLCJAZZ | 1.16% | $780.42K | 3,300 |
| Ascendis Pharma A/S | 1.10% | $739.79K | 3,301 |
| Summit Therapeutics Inc.SMMT | 1.08% | $729.12K | 41,569 |
| Exelixis, Inc.EXEL | 1.04% | $702.83K | 13,923 |
| BridgeBio Pharma, Inc.BBIO | 1.02% | $688.64K | 10,393 |
| Medpace Holdings, Inc.MEDP | 1.01% | $680.50K | 1,522 |
| Ionis Pharmaceuticals, Inc.IONS | 1.01% | $677.48K | 8,856 |
| Axsome Therapeutics, Inc.AXSM | 0.95% | $642.94K | 2,742 |
| Madrigal Pharmaceuticals, Inc.MDGL | 0.91% | $611.64K | 1,230 |
| BioMarin Pharmaceutical Inc.BMRN | 0.88% | $590.72K | 10,311 |
| BioNTech SEBNTX | 0.87% | $586.45K | 6,112 |
| Arrowhead Pharmaceuticals, Inc.ARWR | 0.87% | $584.87K | 7,507 |
| SanofiSNY | 0.85% | $573.04K | 13,122 |
| Praxis Precision Medicines, Inc.PRAX | 0.78% | $522.51K | 1,493 |
| Cytokinetics, Inc.CYTK | 0.75% | $506.39K | 6,597 |
| BeOne Medicines Ltd.ONC | 0.73% | $493.49K | 1,714 |
| Krystal Biotech, Inc.KRYS | 0.72% | $484.25K | 1,567 |
| Tempus AI, Inc.TEM | 0.70% | $470.08K | 9,314 |
| Abivax S.A.ABVX | 0.65% | $436.88K | 3,294 |
| Nuvalent, Inc. | 0.64% | $433.06K | 3,923 |
| Halozyme Therapeutics, Inc.HALO | 0.62% | $421.00K | 6,327 |
| ImmunityBio, Inc.IBRX | 0.62% | $414.49K | 55,119 |
| Vaxcyte, Inc.PCVX | 0.59% | $396.60K | 7,716 |
| Alkermes PLC | 0.56% | $376.93K | 8,934 |
| Immunovant, Inc.IMVT | 0.54% | $363.37K | 10,912 |
| Kymera Therapeutics, Inc.KYMR | 0.53% | $356.38K | 4,377 |
| Protagonist Therapeutics, Inc.PTGX | 0.51% | $340.59K | 3,421 |
| Mirum Pharmaceuticals, Inc.MIRM | 0.49% | $328.35K | 3,235 |
| PTC Therapeutics, Inc.PTCT | 0.49% | $327.38K | 4,433 |
| Rhythm Pharmaceuticals, Inc.RYTM | 0.48% | $323.34K | 3,661 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.